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Comments on




Those ERN/ENet members who remained for Saturday morning’s
featured speaker were richly rewarded by Dr. Thomas C. Chalmers’s
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discussion of his reseach program pertaining to the quality of clinical
trials. During this 15-20-year period, Dr. Chalmers has been an outspoken
champion of the need for randomized controlled trials (RCTs) in medicine
while serving as President and Dean of Mt. Sinai Medical Center.
Dr. Chalmers’s presentation was particularly relevant to members of
the evaluation comunity in dealing with many issues germane to non-
medical settings. In fact, to those familiar with the Campbell and Stanley
threats to validity framework, the problems confronted are strikingly
similar to those encountered in our own research during the past couple of
decades. However, the analyses conducted and the solutions suggested
offer a unique perspective for understanding the pattern of research results
in our own fields of inquiry.
The presentation itself was heavily data-based and centered on two
themes: the role of study quality in the particular inferences that are made,
and the use of data synthesis techniques to assess what is known about a
particular treatment. Numerous slides of tables and graphs taken from
previous studies were utilized to illustrate these two themes.
A critical shortcoming of many clinical studies has been the failure to
establish proper control groups that use randomization to assign patients
to the conditions of an experiment. Instead, medical researchers have
utilized historical controls (groups of patients who have not received the
treatment of interest whose data are taken from a previous time period) to
argue for the effectiveness of treatment. Chalmers and his colleagues have
demonstrated quite cogently across a number of examples that the result
of this practice of using historical rather than randomized controls has
been to overestimate consistently the benefit of treatment. In this context
it is easy to understand another interesting finding of Chalmers’s
research-that authors express much more enthusiasm for study results
that have used poorer controls while expressing less enthusiasm for studies
that have used better controls. For these and other reasons Dr. Chalmers
has urged medical researchers to employ RCTs, arguing that randomiza-
tion should proceed with the first patient that could potentially receive
treatment.
The second major theme of Dr. Chalmers’s presentation centered on
the utility of research synthesis in medical research. Since innovations in
the medical field are characterized by small benefits and individual studies
typically involve small sample sizes, Dr. Chalmers argued that synthesis
efforts are necessary to identify effective interventions. This strategy
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would minimize the risk of labeling as useless treatments that appear to be
ineffective due to the lack of statistical power. In a particularly provoca-
tive application of research synthesis, Dr. Chalmers demonstrated graphi-
cally how the results of studies could be cumulated across time to identify
the precise period needed before a decision regarding treatment effective-
ness could be made. Thus, effective medical technologies can be dissemi-
nated more widely and potentially harmful technologies abandoned with-
out undue delay.
The invited address provided the evaluation community the oppor-
tunity to acknowledge the pioneering efforts of Dr. Chalmers to enhance
research quality by arguing for randomized controls in medical research.
It also made quite clear his early role in developing data synthesis proce-
dures as well as the potential value of research synthesis techniques in
evaluation research, an area also plagued by small benefits and small
samples. Most remarkable of all is the fact that this novel and important
research work was conducted while Dr. Chalmers served as President and
Dean of Mt. Sinai Medical Center. And given that Dr. Chalmers is
spending a portion of his sabbatical year with Dr. Frederick Mosteller at
Harvard, we can look forward to still other influential contributions to the
evaluation of clinical trials.
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